the results of a multicentre clinical trial of prostaglandin e2 ( pge2 ) administered by the vaginal route in the management of intrauterine fetal death and missed abortion showed an overall efficacy of 97 per cent .
C0012472
prostaglandin e2
C0015927
intrauterine fetal death